Index by author

01 September 2009; volume 34, issue 3

A

  1. Abbink, J.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  2. Accordini, S.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  3. Agusti, A.

    1. Zhu, G. et al "CTLA4 gene polymorphisms are associated with chronic bronchitis." European Respiratory Journal 34.3 (2009): 598-604. Web. 01 Oct. 2022.

  4. Anderson, J. A.

    1. Crim, C. et al "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." European Respiratory Journal 34.3 (2009): 641-647. Web. 01 Oct. 2022.

  5. Andersson, B.

    1. Selimovic, N. et al "Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension." European Respiratory Journal 34.3 (2009): 662-668. Web. 01 Oct. 2022.

  6. Ansaldo, E.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  7. Antó, J. M.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

B

  1. Bakke, P.

    1. Zhu, G. et al "CTLA4 gene polymorphisms are associated with chronic bronchitis." European Respiratory Journal 34.3 (2009): 598-604. Web. 01 Oct. 2022.

  2. Baraket, M.

    1. Klagas, I. et al "Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD." European Respiratory Journal 34.3 (2009): 616-628. Web. 01 Oct. 2022.

  3. Bausch, B.

    1. Strassmann, R. et al "Smoking cessation interventions in COPD: a network meta-analysis of randomised trials." European Respiratory Journal 34.3 (2009): 634-640. Web. 01 Oct. 2022.

  4. Beauchesne, M-F.

    1. Martel, M-J. et al "Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case–control study." European Respiratory Journal 34.3 (2009): 579-587. Web. 01 Oct. 2022.

  5. Belperio, J. A.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

  6. Bergh, C-H.

    1. Selimovic, N. et al "Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension." European Respiratory Journal 34.3 (2009): 662-668. Web. 01 Oct. 2022.

  7. Berry, P.

    1. Jones, P. W. et al "Development and first validation of the COPD Assessment Test." European Respiratory Journal 34.3 (2009): 648-654. Web. 01 Oct. 2022.

  8. Bienvenu, T.

    1. Fajac, I. et al "Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease." European Respiratory Journal 34.3 (2009): 772-773. Web. 01 Oct. 2022.

  9. Black, J. L.

    1. Klagas, I. et al "Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD." European Respiratory Journal 34.3 (2009): 616-628. Web. 01 Oct. 2022.

  10. Blais, L.

    1. Martel, M-J. et al "Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case–control study." European Respiratory Journal 34.3 (2009): 579-587. Web. 01 Oct. 2022.

  11. Bogaard, H-J.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  12. Boner, A. L.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  13. Bont, L.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  14. Boonstra, A.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  15. Boukas, K.

    1. Stamatiou, R. et al "Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells." European Respiratory Journal 34.3 (2009): 721-730. Web. 01 Oct. 2022.

  16. Braendli, O.

    1. Strassmann, R. et al "Smoking cessation interventions in COPD: a network meta-analysis of randomised trials." European Respiratory Journal 34.3 (2009): 634-640. Web. 01 Oct. 2022.

  17. Brennan, S.

    1. Brennan, S. et al "Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis." European Respiratory Journal 34.3 (2009): 655-661. Web. 01 Oct. 2022.

  18. Bridevaux, P-O.

    1. Bridevaux, P-O., M. Gerbase, and T. Rochat. " From the authors: ." European Respiratory Journal 34.3 (2009): 777. Web. 01 Oct. 2022.

  19. Brusasco, V.

    1. Miller, M. R. et al "Debating the definition of airflow obstruction: time to move on?." European Respiratory Journal 34.3 (2009): 527-528. Web. 01 Oct. 2022.

  20. Buist, A. S.

    1. Vollmer, W. M. et al "Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study." European Respiratory Journal 34.3 (2009): 588-597. Web. 01 Oct. 2022.

  21. Burdick, M. D.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

  22. Burge, C. B. S. G.

    1. Park, D. et al "Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma." European Respiratory Journal 34.3 (2009): 574-578. Web. 01 Oct. 2022.

  23. Burge, P. S.

    1. Park, D. et al "Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma." European Respiratory Journal 34.3 (2009): 574-578. Web. 01 Oct. 2022.

  24. Burney, P.

    1. Vollmer, W. M. et al "Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study." European Respiratory Journal 34.3 (2009): 588-597. Web. 01 Oct. 2022.

  25. Bush, A.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  26. Busuttil, A.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

C

  1. Calverley, P. M. A.

    1. Crim, C. et al "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." European Respiratory Journal 34.3 (2009): 641-647. Web. 01 Oct. 2022.

  2. Carlsen, K-H.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  3. Carlsten, H.

    1. Selimovic, N. et al "Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension." European Respiratory Journal 34.3 (2009): 662-668. Web. 01 Oct. 2022.

  4. Casaburi, R.

    1. Hsia, D. et al "Physiological responses to linear treadmill and cycle ergometer exercise in COPD." European Respiratory Journal 34.3 (2009): 605-615. Web. 01 Oct. 2022.

  5. Casanova, C.

    1. de Torres, J. P., C. Casanova, and B. R. Celli. "Sex, forced expiratory volume in 1 s decline, body weight change and C-reactive protein in COPD patients." European Respiratory Journal 34.3 (2009): 776. Web. 01 Oct. 2022.

  6. Cazzola, M.

    1. Cazzola, M., and M. G. Matera. "Emerging inhaled bronchodilators: an update." European Respiratory Journal 34.3 (2009): 757-769. Web. 01 Oct. 2022.

  7. Celli, B.

    1. Crim, C. et al "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." European Respiratory Journal 34.3 (2009): 641-647. Web. 01 Oct. 2022.

  8. Celli, B. R.

    1. de Torres, J. P., C. Casanova, and B. R. Celli. "Sex, forced expiratory volume in 1 s decline, body weight change and C-reactive protein in COPD patients." European Respiratory Journal 34.3 (2009): 776. Web. 01 Oct. 2022.

  9. Centis, R.

    1. Migliori, G. B. et al "MDR-TB and XDR-TB: drug resistance and treatment outcomes." European Respiratory Journal 34.3 (2009): 778-779. Web. 01 Oct. 2022.

  10. Cerveri, I.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  11. Cervio, G.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  12. Chen, W-H.

    1. Jones, P. W. et al "Development and first validation of the COPD Assessment Test." European Respiratory Journal 34.3 (2009): 648-654. Web. 01 Oct. 2022.

  13. Clancy, L.

    1. Kabir, Z. et al "Second-hand smoke exposure in cars and respiratory health effects in children." European Respiratory Journal 34.3 (2009): 629-633. Web. 01 Oct. 2022.

  14. Cormier, Y.

    1. Girard, M., E. Israël-Assayag, and Y. Cormier. "Mature CD11c+ cells are enhanced in hypersensitivity pneumonitis." European Respiratory Journal 34.3 (2009): 749-756. Web. 01 Oct. 2022.

  15. Corsico, A. G.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  16. Coxson, H.

    1. Zhu, G. et al "CTLA4 gene polymorphisms are associated with chronic bronchitis." European Respiratory Journal 34.3 (2009): 598-604. Web. 01 Oct. 2022.

  17. Crim, C.

    1. Crim, C. et al "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." European Respiratory Journal 34.3 (2009): 641-647. Web. 01 Oct. 2022.

D

  1. D'Arcy Richardson, M.

    1. Migliori, G. B. et al "MDR-TB and XDR-TB: drug resistance and treatment outcomes." European Respiratory Journal 34.3 (2009): 778-779. Web. 01 Oct. 2022.

  2. de Benedictis, F. M.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  3. Decante, B.

    1. Le Pavec, J. et al "Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats." European Respiratory Journal 34.3 (2009): 731-739. Web. 01 Oct. 2022.

  4. de Koning, H. J.

    1. van den Bergh, K. A. M. et al "Informed participation in a randomised controlled trial of computed tomography screening for lung cancer." European Respiratory Journal 34.3 (2009): 711-720. Web. 01 Oct. 2022.

  5. de Man, F. S.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  6. de Marco, R.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  7. de Torres, J. P.

    1. de Torres, J. P., C. Casanova, and B. R. Celli. "Sex, forced expiratory volume in 1 s decline, body weight change and C-reactive protein in COPD patients." European Respiratory Journal 34.3 (2009): 776. Web. 01 Oct. 2022.

  8. Dimitrokalli, P.

    1. Koutsourelakis, I. et al "Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients." European Respiratory Journal 34.3 (2009): 687-693. Web. 01 Oct. 2022.

  9. Dorfmuller, P.

    1. Le Pavec, J. et al "Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats." European Respiratory Journal 34.3 (2009): 731-739. Web. 01 Oct. 2022.

  10. Du, X.

    1. Song, Y., X. Li, and X. Du. "Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma." European Respiratory Journal 34.3 (2009): 559-567. Web. 01 Oct. 2022.

E

  1. Eber, E.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  2. Economou, N. T.

    1. Koutsourelakis, I. et al "Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients." European Respiratory Journal 34.3 (2009): 687-693. Web. 01 Oct. 2022.

  3. Eddahibi, S.

    1. Le Pavec, J. et al "Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats." European Respiratory Journal 34.3 (2009): 731-739. Web. 01 Oct. 2022.

  4. Elashoff, R. M.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

  5. Enright, P. L.

    1. Vollmer, W. M. et al "Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study." European Respiratory Journal 34.3 (2009): 588-597. Web. 01 Oct. 2022.

  6. Essink-Bot, M. L.

    1. van den Bergh, K. A. M. et al "Informed participation in a randomised controlled trial of computed tomography screening for lung cancer." European Respiratory Journal 34.3 (2009): 711-720. Web. 01 Oct. 2022.

F

  1. Facchini, A.

    1. Migliori, G. B. et al "MDR-TB and XDR-TB: drug resistance and treatment outcomes." European Respiratory Journal 34.3 (2009): 778-779. Web. 01 Oct. 2022.

  2. Fajac, I.

    1. Fajac, I. et al "Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease." European Respiratory Journal 34.3 (2009): 772-773. Web. 01 Oct. 2022.

  3. Fauroux, B.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  4. Ferguson, G. T.

    1. Crim, C. et al "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." European Respiratory Journal 34.3 (2009): 641-647. Web. 01 Oct. 2022.

  5. Ferland, A.

    1. Ferland, A., P. Poirier, and F. Sériès. "Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients." European Respiratory Journal 34.3 (2009): 694-701. Web. 01 Oct. 2022.

  6. Fishbein, M.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

  7. Forget, A.

    1. Martel, M-J. et al "Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case–control study." European Respiratory Journal 34.3 (2009): 579-587. Web. 01 Oct. 2022.

G

  1. Gaine, S. P.

    1. Lavelle, A. et al "Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 770-771. Web. 01 Oct. 2022.

  2. Gaitch, N.

    1. Fajac, I. et al "Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease." European Respiratory Journal 34.3 (2009): 772-773. Web. 01 Oct. 2022.

  3. Gangell, C. L.

    1. Brennan, S. et al "Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis." European Respiratory Journal 34.3 (2009): 655-661. Web. 01 Oct. 2022.

  4. Gard, S.

    1. Brennan, S. et al "Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis." European Respiratory Journal 34.3 (2009): 655-661. Web. 01 Oct. 2022.

  5. Gerbase, M.

    1. Bridevaux, P-O., M. Gerbase, and T. Rochat. " From the authors: ." European Respiratory Journal 34.3 (2009): 777. Web. 01 Oct. 2022.

  6. Girard, M.

    1. Girard, M., E. Israël-Assayag, and Y. Cormier. "Mature CD11c+ cells are enhanced in hypersensitivity pneumonitis." European Respiratory Journal 34.3 (2009): 749-756. Web. 01 Oct. 2022.

  7. Gíslason, Þ.

    1. Vollmer, W. M. et al "Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study." European Respiratory Journal 34.3 (2009): 588-597. Web. 01 Oct. 2022.

  8. Goodman, P. G.

    1. Kabir, Z. et al "Second-hand smoke exposure in cars and respiratory health effects in children." European Respiratory Journal 34.3 (2009): 629-633. Web. 01 Oct. 2022.

  9. Götz, M.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  10. Goulet, S.

    1. Klagas, I. et al "Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD." European Respiratory Journal 34.3 (2009): 616-628. Web. 01 Oct. 2022.

  11. Gourgoulianis, K. I.

    1. Stamatiou, R. et al "Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells." European Respiratory Journal 34.3 (2009): 721-730. Web. 01 Oct. 2022.

  12. Greenough, A.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  13. Grigg, J.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  14. Groepenhoff, H.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  15. Grosso, A.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  16. Grotjohan, H. P.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  17. Guenther, G.

    1. Migliori, G. B. et al "MDR-TB and XDR-TB: drug resistance and treatment outcomes." European Respiratory Journal 34.3 (2009): 778-779. Web. 01 Oct. 2022.

  18. Gulsvik, A.

    1. Vollmer, W. M. et al "Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study." European Respiratory Journal 34.3 (2009): 588-597. Web. 01 Oct. 2022.
    2. Zhu, G. et al "CTLA4 gene polymorphisms are associated with chronic bronchitis." European Respiratory Journal 34.3 (2009): 598-604. Web. 01 Oct. 2022.

H

  1. Handoko, M. L.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  2. Harding, G.

    1. Jones, P. W. et al "Development and first validation of the COPD Assessment Test." European Respiratory Journal 34.3 (2009): 648-654. Web. 01 Oct. 2022.

  3. Harrison, R.

    1. Jeebun, V., S. Natu, and R. Harrison. "Diagnosis of a posterior mediastinal goitre via endobronchial ultrasound-guided transbronchial needle aspiration." European Respiratory Journal 34.3 (2009): 773-775. Web. 01 Oct. 2022.

  4. Hatziefthimiou, A. A.

    1. Stamatiou, R. et al "Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells." European Respiratory Journal 34.3 (2009): 721-730. Web. 01 Oct. 2022.

  5. Heinrich, J.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  6. Herve, P.

    1. Le Pavec, J. et al "Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats." European Respiratory Journal 34.3 (2009): 731-739. Web. 01 Oct. 2022.

  7. Hoeper, M. M.

    1. Hoeper, M. M.. "Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy?." European Respiratory Journal 34.3 (2009): 529-530. Web. 01 Oct. 2022.

  8. Holohan, J.

    1. Kabir, Z. et al "Second-hand smoke exposure in cars and respiratory health effects in children." European Respiratory Journal 34.3 (2009): 629-633. Web. 01 Oct. 2022.

  9. Hsia, D.

    1. Hsia, D. et al "Physiological responses to linear treadmill and cycle ergometer exercise in COPD." European Respiratory Journal 34.3 (2009): 605-615. Web. 01 Oct. 2022.

  10. Huang, C.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

  11. Hubert, D.

    1. Fajac, I. et al "Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease." European Respiratory Journal 34.3 (2009): 772-773. Web. 01 Oct. 2022.

  12. Huggett, J.

    1. Migliori, G.B., and J. Huggett. "Tuberculosis: A Comprehensive Clinical Reference." European Respiratory Journal 34.3 (2009): 785. Web. 01 Oct. 2022.

  13. Hull, J.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  14. Humbert, M.

    1. Le Pavec, J. et al "Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats." European Respiratory Journal 34.3 (2009): 731-739. Web. 01 Oct. 2022.

  15. Hwang, S. S.

    1. Hwang, S. S., and J-J. Yim. " From the authors: ." European Respiratory Journal 34.3 (2009): 780-781. Web. 01 Oct. 2022.

I

  1. Israël-Assayag, E.

    1. Girard, M., E. Israël-Assayag, and Y. Cormier. "Mature CD11c+ cells are enhanced in hypersensitivity pneumonitis." European Respiratory Journal 34.3 (2009): 749-756. Web. 01 Oct. 2022.

J

  1. Jaakkola, M. S.

    1. Park, D. et al "Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma." European Respiratory Journal 34.3 (2009): 574-578. Web. 01 Oct. 2022.

  2. Janson, C.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  3. Jeebun, V.

    1. Jeebun, V., S. Natu, and R. Harrison. "Diagnosis of a posterior mediastinal goitre via endobronchial ultrasound-guided transbronchial needle aspiration." European Respiratory Journal 34.3 (2009): 773-775. Web. 01 Oct. 2022.

  4. Jenkins, C.

    1. Crim, C. et al "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." European Respiratory Journal 34.3 (2009): 641-647. Web. 01 Oct. 2022.

  5. Jones, P. W.

    1. Crim, C. et al "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." European Respiratory Journal 34.3 (2009): 641-647. Web. 01 Oct. 2022.
    2. Jones, P. W. et al "Development and first validation of the COPD Assessment Test." European Respiratory Journal 34.3 (2009): 648-654. Web. 01 Oct. 2022.

K

  1. Kabir, Z.

    1. Kabir, Z. et al "Second-hand smoke exposure in cars and respiratory health effects in children." European Respiratory Journal 34.3 (2009): 629-633. Web. 01 Oct. 2022.

  2. Karakiulakis, G.

    1. Klagas, I. et al "Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD." European Respiratory Journal 34.3 (2009): 616-628. Web. 01 Oct. 2022.

  3. Keane, M. P.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

  4. Kelleher, B.

    1. Lavelle, A. et al "Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 770-771. Web. 01 Oct. 2022.

  5. Keogan, S.

    1. Kabir, Z. et al "Second-hand smoke exposure in cars and respiratory health effects in children." European Respiratory Journal 34.3 (2009): 629-633. Web. 01 Oct. 2022.

  6. Khurana, A. K.

    1. Khurana, A. K., and P. R. Mohapatra. " To the Editors: ." European Respiratory Journal 34.3 (2009): 780. Web. 01 Oct. 2022.

  7. Kimpen, J.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  8. Kimura, H.

    1. Kumamoto, M. et al "Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury." European Respiratory Journal 34.3 (2009): 740-748. Web. 01 Oct. 2022.

  9. Klagas, I.

    1. Klagas, I. et al "Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD." European Respiratory Journal 34.3 (2009): 616-628. Web. 01 Oct. 2022.

  10. Kleijnen, J.

    1. Strassmann, R. et al "Smoking cessation interventions in COPD: a network meta-analysis of randomised trials." European Respiratory Journal 34.3 (2009): 634-640. Web. 01 Oct. 2022.

  11. Kline Leidy, N.

    1. Jones, P. W. et al "Development and first validation of the COPD Assessment Test." European Respiratory Journal 34.3 (2009): 648-654. Web. 01 Oct. 2022.

  12. Kocabas, A.

    1. Vollmer, W. M. et al "Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study." European Respiratory Journal 34.3 (2009): 588-597. Web. 01 Oct. 2022.

  13. Koppers, R. J. H.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  14. Koutsourelakis, I.

    1. Koutsourelakis, I. et al "Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients." European Respiratory Journal 34.3 (2009): 687-693. Web. 01 Oct. 2022.

  15. Kumamoto, M.

    1. Kumamoto, M. et al "Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury." European Respiratory Journal 34.3 (2009): 740-748. Web. 01 Oct. 2022.

  16. Künzli, N.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

L

  1. Lange, C.

    1. Migliori, G. B. et al "MDR-TB and XDR-TB: drug resistance and treatment outcomes." European Respiratory Journal 34.3 (2009): 778-779. Web. 01 Oct. 2022.

  2. Lavelle, A.

    1. Lavelle, A. et al "Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 770-771. Web. 01 Oct. 2022.

  3. Lawler, G.

    1. Lavelle, A. et al "Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 770-771. Web. 01 Oct. 2022.

  4. Lebrec, D.

    1. Le Pavec, J. et al "Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats." European Respiratory Journal 34.3 (2009): 731-739. Web. 01 Oct. 2022.

  5. Lenney, W.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  6. Le Pavec, J.

    1. Le Pavec, J. et al "Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats." European Respiratory Journal 34.3 (2009): 731-739. Web. 01 Oct. 2022.

  7. Li, X.

    1. Song, Y., X. Li, and X. Du. "Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma." European Respiratory Journal 34.3 (2009): 559-567. Web. 01 Oct. 2022.

  8. Lomas, D. A.

    1. Zhu, G. et al "CTLA4 gene polymorphisms are associated with chronic bronchitis." European Respiratory Journal 34.3 (2009): 598-604. Web. 01 Oct. 2022.

  9. Lynch, J. P.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

M

  1. Malo, J-L.

    1. Martel, M-J. et al "Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case–control study." European Respiratory Journal 34.3 (2009): 579-587. Web. 01 Oct. 2022.

  2. Manning, P. J.

    1. Kabir, Z. et al "Second-hand smoke exposure in cars and respiratory health effects in children." European Respiratory Journal 34.3 (2009): 629-633. Web. 01 Oct. 2022.

  3. Martel, M-J.

    1. Martel, M-J. et al "Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case–control study." European Respiratory Journal 34.3 (2009): 579-587. Web. 01 Oct. 2022.

  4. Matera, M. G.

    1. Cazzola, M., and M. G. Matera. "Emerging inhaled bronchodilators: an update." European Respiratory Journal 34.3 (2009): 757-769. Web. 01 Oct. 2022.

  5. Matsuo, N.

    1. Kumamoto, M. et al "Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury." European Respiratory Journal 34.3 (2009): 740-748. Web. 01 Oct. 2022.

  6. Matsushima, K.

    1. Kumamoto, M. et al "Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury." European Respiratory Journal 34.3 (2009): 740-748. Web. 01 Oct. 2022.

  7. Mazmanian, M.

    1. Le Pavec, J. et al "Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats." European Respiratory Journal 34.3 (2009): 731-739. Web. 01 Oct. 2022.

  8. Migliori, G. B.

    1. Migliori, G. B. et al "MDR-TB and XDR-TB: drug resistance and treatment outcomes." European Respiratory Journal 34.3 (2009): 778-779. Web. 01 Oct. 2022.

  9. Migliori, G.B.

    1. Migliori, G.B., and J. Huggett. "Tuberculosis: A Comprehensive Clinical Reference." European Respiratory Journal 34.3 (2009): 785. Web. 01 Oct. 2022.

  10. Miller, M. R.

    1. Miller, M. R. et al "Debating the definition of airflow obstruction: time to move on?." European Respiratory Journal 34.3 (2009): 527-528. Web. 01 Oct. 2022.

  11. Mohapatra, P. R.

    1. Khurana, A. K., and P. R. Mohapatra. " To the Editors: ." European Respiratory Journal 34.3 (2009): 780. Web. 01 Oct. 2022.

  12. Molyvdas, P-A.

    1. Stamatiou, R. et al "Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells." European Respiratory Journal 34.3 (2009): 721-730. Web. 01 Oct. 2022.

  13. Moore, V. C.

    1. Park, D. et al "Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma." European Respiratory Journal 34.3 (2009): 574-578. Web. 01 Oct. 2022.

  14. Mulligan, N.

    1. Lavelle, A. et al "Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 770-771. Web. 01 Oct. 2022.

  15. Murphy, D. M.

    1. Lavelle, A. et al "Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 770-771. Web. 01 Oct. 2022.

N

  1. Natu, S.

    1. Jeebun, V., S. Natu, and R. Harrison. "Diagnosis of a posterior mediastinal goitre via endobronchial ultrasound-guided transbronchial needle aspiration." European Respiratory Journal 34.3 (2009): 773-775. Web. 01 Oct. 2022.

  2. Niniano, R.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  3. Nishiwaki, T.

    1. Kumamoto, M. et al "Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury." European Respiratory Journal 34.3 (2009): 740-748. Web. 01 Oct. 2022.

P

  1. Palchevskiy, V.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

  2. Papakonstantinou, E.

    1. Klagas, I. et al "Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD." European Respiratory Journal 34.3 (2009): 616-628. Web. 01 Oct. 2022.

  3. Paraskeva, E.

    1. Stamatiou, R. et al "Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells." European Respiratory Journal 34.3 (2009): 721-730. Web. 01 Oct. 2022.

  4. Park, D.

    1. Park, D. et al "Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma." European Respiratory Journal 34.3 (2009): 574-578. Web. 01 Oct. 2022.

  5. Pedersen, O. F.

    1. Miller, M. R. et al "Debating the definition of airflow obstruction: time to move on?." European Respiratory Journal 34.3 (2009): 527-528. Web. 01 Oct. 2022.

  6. Pellegrino, R.

    1. Miller, M. R. et al "Debating the definition of airflow obstruction: time to move on?." European Respiratory Journal 34.3 (2009): 527-528. Web. 01 Oct. 2022.

  7. Perraki, E.

    1. Koutsourelakis, I. et al "Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients." European Respiratory Journal 34.3 (2009): 687-693. Web. 01 Oct. 2022.

  8. Perreault, S.

    1. Martel, M-J. et al "Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case–control study." European Respiratory Journal 34.3 (2009): 579-587. Web. 01 Oct. 2022.

  9. Perros, F.

    1. Le Pavec, J. et al "Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats." European Respiratory Journal 34.3 (2009): 731-739. Web. 01 Oct. 2022.

  10. Pillai, S. G.

    1. Zhu, G. et al "CTLA4 gene polymorphisms are associated with chronic bronchitis." European Respiratory Journal 34.3 (2009): 598-604. Web. 01 Oct. 2022.

  11. Poirier, P.

    1. Ferland, A., P. Poirier, and F. Sériès. "Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients." European Respiratory Journal 34.3 (2009): 694-701. Web. 01 Oct. 2022.

  12. Porszasz, J.

    1. Hsia, D. et al "Physiological responses to linear treadmill and cycle ergometer exercise in COPD." European Respiratory Journal 34.3 (2009): 605-615. Web. 01 Oct. 2022.

  13. Postmus, P. E.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  14. Pozzi, E.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  15. Pradhan, A.

    1. Hsia, D. et al "Physiological responses to linear treadmill and cycle ergometer exercise in COPD." European Respiratory Journal 34.3 (2009): 605-615. Web. 01 Oct. 2022.

  16. Puhan, M. A.

    1. Puhan, M. A., and H. J. Schünemann. "How to increase the value of randomised trials in COPD research." European Respiratory Journal 34.3 (2009): 552-558. Web. 01 Oct. 2022.
    2. Strassmann, R. et al "Smoking cessation interventions in COPD: a network meta-analysis of randomised trials." European Respiratory Journal 34.3 (2009): 634-640. Web. 01 Oct. 2022.

R

  1. Rey, É.

    1. Martel, M-J. et al "Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case–control study." European Respiratory Journal 34.3 (2009): 579-587. Web. 01 Oct. 2022.

  2. Robertson, A. S.

    1. Park, D. et al "Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma." European Respiratory Journal 34.3 (2009): 574-578. Web. 01 Oct. 2022.

  3. Rochat, T.

    1. Bridevaux, P-O., M. Gerbase, and T. Rochat. " From the authors: ." European Respiratory Journal 34.3 (2009): 777. Web. 01 Oct. 2022.

  4. Roth, M.

    1. Klagas, I. et al "Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD." European Respiratory Journal 34.3 (2009): 616-628. Web. 01 Oct. 2022.

  5. Roussos, C.

    1. Koutsourelakis, I. et al "Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients." European Respiratory Journal 34.3 (2009): 687-693. Web. 01 Oct. 2022.

  6. Rundqvist, B.

    1. Selimovic, N. et al "Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension." European Respiratory Journal 34.3 (2009): 662-668. Web. 01 Oct. 2022.

S

  1. Sakiniene, E.

    1. Selimovic, N. et al "Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension." European Respiratory Journal 34.3 (2009): 662-668. Web. 01 Oct. 2022.

  2. Sánchez Luna, M.

    1. Lenney, W. et al "Medicines used in respiratory diseases only seen in children." European Respiratory Journal 34.3 (2009): 531-551. Web. 01 Oct. 2022.

  3. Schäfers, H-J.

    1. Sester, U. et al "Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs." European Respiratory Journal 34.3 (2009): 702-710. Web. 01 Oct. 2022.

  4. Schouten, J. P.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  5. Schünemann, H. J.

    1. Puhan, M. A., and H. J. Schünemann. "How to increase the value of randomised trials in COPD research." European Respiratory Journal 34.3 (2009): 552-558. Web. 01 Oct. 2022.

  6. Selimovic, N.

    1. Selimovic, N. et al "Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension." European Respiratory Journal 34.3 (2009): 662-668. Web. 01 Oct. 2022.

  7. Sériès, F.

    1. Ferland, A., P. Poirier, and F. Sériès. "Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients." European Respiratory Journal 34.3 (2009): 694-701. Web. 01 Oct. 2022.

  8. Sester, M.

    1. Sester, U. et al "Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs." European Respiratory Journal 34.3 (2009): 702-710. Web. 01 Oct. 2022.

  9. Sester, U.

    1. Sester, U. et al "Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs." European Respiratory Journal 34.3 (2009): 702-710. Web. 01 Oct. 2022.

  10. Silverman, E. K.

    1. Zhu, G. et al "CTLA4 gene polymorphisms are associated with chronic bronchitis." European Respiratory Journal 34.3 (2009): 598-604. Web. 01 Oct. 2022.

  11. Singh, M.

    1. Sester, U. et al "Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs." European Respiratory Journal 34.3 (2009): 702-710. Web. 01 Oct. 2022.

  12. Sitbon, O.

    1. Le Pavec, J. et al "Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats." European Respiratory Journal 34.3 (2009): 731-739. Web. 01 Oct. 2022.

  13. Sly, P. D.

    1. Brennan, S. et al "Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis." European Respiratory Journal 34.3 (2009): 655-661. Web. 01 Oct. 2022.

  14. Song, Y.

    1. Song, Y., X. Li, and X. Du. "Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma." European Respiratory Journal 34.3 (2009): 559-567. Web. 01 Oct. 2022.

  15. Sotgiu, G.

    1. Migliori, G. B. et al "MDR-TB and XDR-TB: drug resistance and treatment outcomes." European Respiratory Journal 34.3 (2009): 778-779. Web. 01 Oct. 2022.

  16. Spaar, A.

    1. Strassmann, R. et al "Smoking cessation interventions in COPD: a network meta-analysis of randomised trials." European Respiratory Journal 34.3 (2009): 634-640. Web. 01 Oct. 2022.

  17. Spanevello, A.

    1. Migliori, G. B. et al "MDR-TB and XDR-TB: drug resistance and treatment outcomes." European Respiratory Journal 34.3 (2009): 778-779. Web. 01 Oct. 2022.

  18. Stamatiou, R.

    1. Stamatiou, R. et al "Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells." European Respiratory Journal 34.3 (2009): 721-730. Web. 01 Oct. 2022.

  19. Strassmann, R.

    1. Strassmann, R. et al "Smoking cessation interventions in COPD: a network meta-analysis of randomised trials." European Respiratory Journal 34.3 (2009): 634-640. Web. 01 Oct. 2022.

  20. Strieter, R. M.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

  21. Sturges, N.

    1. Brennan, S. et al "Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis." European Respiratory Journal 34.3 (2009): 655-661. Web. 01 Oct. 2022.

  22. Sugrue, R.

    1. Lavelle, A. et al "Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 770-771. Web. 01 Oct. 2022.

  23. Sunyer, J.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  24. Svanes, C.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  25. Sybrecht, G. W.

    1. Sester, U. et al "Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs." European Respiratory Journal 34.3 (2009): 702-710. Web. 01 Oct. 2022.

T

  1. Torres, E.

    1. Hsia, D. et al "Physiological responses to linear treadmill and cycle ergometer exercise in COPD." European Respiratory Journal 34.3 (2009): 605-615. Web. 01 Oct. 2022.

  2. Tsana Tegomo, E.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

  3. Twisk, J. W. R.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

U

  1. Upham, J. W.

    1. Brennan, S. et al "Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis." European Respiratory Journal 34.3 (2009): 655-661. Web. 01 Oct. 2022.

V

  1. Vagiakis, E.

    1. Koutsourelakis, I. et al "Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients." European Respiratory Journal 34.3 (2009): 687-693. Web. 01 Oct. 2022.

  2. van 't Hul, A. J.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  3. van Bentum, K.

    1. Sester, U. et al "Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs." European Respiratory Journal 34.3 (2009): 702-710. Web. 01 Oct. 2022.

  4. van den Bergh, K. A. M.

    1. van den Bergh, K. A. M. et al "Informed participation in a randomised controlled trial of computed tomography screening for lung cancer." European Respiratory Journal 34.3 (2009): 711-720. Web. 01 Oct. 2022.

  5. van der Laarse, W. J.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  6. van Klaveren, R. J.

    1. van den Bergh, K. A. M. et al "Informed participation in a randomised controlled trial of computed tomography screening for lung cancer." European Respiratory Journal 34.3 (2009): 711-720. Web. 01 Oct. 2022.

  7. Vestbo, J.

    1. Crim, C. et al "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." European Respiratory Journal 34.3 (2009): 641-647. Web. 01 Oct. 2022.

  8. Viel, M.

    1. Fajac, I. et al "Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease." European Respiratory Journal 34.3 (2009): 772-773. Web. 01 Oct. 2022.

  9. Vollmer, W. M.

    1. Vollmer, W. M. et al "Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study." European Respiratory Journal 34.3 (2009): 588-597. Web. 01 Oct. 2022.

  10. Vonk-Noordegraaf, A.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

W

  1. Weigt, S. S.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

  2. Westerhof, N.

    1. de Man, F. S. et al "Effects of exercise training in patients with idiopathic pulmonary arterial hypertension." European Respiratory Journal 34.3 (2009): 669-675. Web. 01 Oct. 2022.

  3. Wiklund, I.

    1. Jones, P. W. et al "Development and first validation of the COPD Assessment Test." European Respiratory Journal 34.3 (2009): 648-654. Web. 01 Oct. 2022.

  4. Wikstrom, M.

    1. Brennan, S. et al "Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis." European Respiratory Journal 34.3 (2009): 655-661. Web. 01 Oct. 2022.

  5. Wilkens, H.

    1. Sester, U. et al "Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs." European Respiratory Journal 34.3 (2009): 702-710. Web. 01 Oct. 2022.

  6. Willits, L. R.

    1. Crim, C. et al "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." European Respiratory Journal 34.3 (2009): 641-647. Web. 01 Oct. 2022.

  7. Winfield, K.

    1. Brennan, S. et al "Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis." European Respiratory Journal 34.3 (2009): 655-661. Web. 01 Oct. 2022.

  8. Wjst, M.

    1. Cerveri, I. et al "What defines airflow obstruction in asthma?." European Respiratory Journal 34.3 (2009): 568-573. Web. 01 Oct. 2022.

X

  1. Xue, Y. Y.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.

Y

  1. Yates, J. C.

    1. Crim, C. et al "Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results." European Respiratory Journal 34.3 (2009): 641-647. Web. 01 Oct. 2022.

  2. Yim, J-J.

    1. Hwang, S. S., and J-J. Yim. " From the authors: ." European Respiratory Journal 34.3 (2009): 780-781. Web. 01 Oct. 2022.

Z

  1. Zakynthinos, S.

    1. Koutsourelakis, I. et al "Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients." European Respiratory Journal 34.3 (2009): 687-693. Web. 01 Oct. 2022.

  2. Zhong, J.

    1. Klagas, I. et al "Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD." European Respiratory Journal 34.3 (2009): 616-628. Web. 01 Oct. 2022.

  3. Zhu, G.

    1. Zhu, G. et al "CTLA4 gene polymorphisms are associated with chronic bronchitis." European Respiratory Journal 34.3 (2009): 598-604. Web. 01 Oct. 2022.

  4. Zisman, D. A.

    1. Busuttil, A. et al "CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis." European Respiratory Journal 34.3 (2009): 676-686. Web. 01 Oct. 2022.
Back to top
European Respiratory Journal: 34 (3)

Search Within This Issue

Jump to

Manage Table of content Alerts